ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Radicava, Infusionslösung - 2
66492001 Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Lenzburg
Radicava, Infusionslösung31.01.2019
  31.01.2019
Edaravone (N07XX14) 
WHO-DDD 
2
01.99. 
B  
No 
IP 
PR  
k.A.PR
  
7680664920017Synthetika
  
Composition
edaravonum 30 mg, E 222 20 mg, cysteini hydrochloridum monohydricum, natrii chloridum, natrii hydroxidum, acidum phosphoricum, aqua ad iniectabile q.s. ad solutionem pro 100 ml corresp. natrium 340.8 mg.
Packungsbestandteile
Infusion solution
 
 
Active AgentDose
Edaravonum30mg / 100ml
 
Inactive agentsDoseadditional_information
Phosphoric Acid  
Cystein Hydrochloride Monohydrate  
E 22220mg / 100mlconserv.
Sodium Chloride  
Sodium Hydroxide  
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home